Article Information
History
- July 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jun-Tao Huang,
- Jian-Hong Zhong,
- Jie Zhang,
- Wen-Feng Gong,
- Liang Ma,
- Le-Qun Li and
- Bang-De Xiang*
- ↵*Correspondence to:
Bang-De Xiang Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, He Di Rd., #71, Nanning 530021, P.R. China. Tel: +86-771-5330855 (office). Fax: +86-771-5312000. Email: xiangbangde{at}gxmu.edu.cn
Author contributions: B.-D.X and J.-H.Z conceived the study; all authors collected and analyzed the data; J.-H.Z analyzed data; J.-T.H and J.-H.Z drafted the manuscript; B.-D.X and J.-H.Z revised the manuscript; all authors read and approved the final version to be published.
Posted July 31, 2022.
Hepatectomy combined with targeted and immunotherapy for CNLC stage IIIb hepatocellular carcinoma: a single-arm clinical trials protocol
